Free Trial

SELLAS Life Sciences Group (SLS) Earnings Date, Estimates & Call Transcripts

SELLAS Life Sciences Group logo
$1.20 +0.02 (+1.27%)
As of 10:50 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SELLAS Life Sciences Group Latest Earnings Summary

Upcoming Q1
Earnings Date
Mar. 27Estimated
Actual EPS
(Mar. 20)
-$0.08 Beat By $0.03
Consensus EPS
(Mar. 20)
-$0.11

SELLAS Life Sciences Group announced Q4 2024 earnings on March 20, 2025, reporting an EPS of -$0.08, which topped analysts' consensus estimates of -$0.11 by $0.03. With a trailing EPS of -$0.52, SELLAS Life Sciences Group's earnings are expected to grow next year, from ($0.57) to ($0.42) per share.

SLS Upcoming Earnings

SELLAS Life Sciences Group's next earnings date is estimated for Thursday, March 27, 2025, based off prior year's reporting schedules.

Get SELLAS Life Sciences Group Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SELLAS Life Sciences Group and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SLS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SLS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

SELLAS Life Sciences Group Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.57) EPS
Next Year EPS Consensus Estimate: ($0.42) EPS
Remove Ads

SELLAS Life Sciences Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/27/2025
(Estimated)
-------
3/20/2025Q4 2024-$0.1067-$0.08+$0.0267-$0.08--
8/13/2024--$0.16-$0.13+$0.03-$0.13--
5/14/2024Q1 2024--$0.21 -$0.21-$0.21--
3/28/2024Q4 2023--$0.25 -$0.25-$0.25--
11/9/2023Q3 2023--$0.33 -$0.33-$0.33--
8/10/2023Q2 2023--$0.31 -$0.31-$0.31--
5/11/2023Q1 2023--$0.47 -$0.47-$0.47--
3/30/2023Q4 2022--$0.15 -$0.15-$0.15--

SELLAS Life Sciences Group Earnings - Frequently Asked Questions

SELLAS Life Sciences Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates. Learn more on SLS's earnings history.

In the previous quarter, SELLAS Life Sciences Group (NASDAQ:SLS) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.03. Learn more on analysts' earnings estimate vs. SLS's actual earnings.

SELLAS Life Sciences Group's earnings report can be found in their filing with the SEC.
View SEC filing

SELLAS Life Sciences Group (NASDAQ:SLS) has a recorded annual revenue of $1 million.

SELLAS Life Sciences Group (NASDAQ:SLS) has a recorded net income of -$37.34 million. SLS has generated -$0.52 earnings per share over the last four quarters.

SELLAS Life Sciences Group's earnings are expected to grow from ($0.57) per share to ($0.42) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:SLS) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners